Simvastatin inhibits prostatic hyperplasia in rats with metabolic syndrome.

Yi Ming GongXing WangSong LiuXue Chun HuYan XuTao Huang

Published in: International urology and nephrology (2022)

MetS induced by HFD is an important factor in the induction of BPH. Simvastatin can alleviate the hyperplasia of prostate through the relief of local inflammation in prostatic tissue.

Keyphrases

benign prostatic hyperplasia
lower urinary tract symptoms
metabolic syndrome
oxidative stress
high fat diet
insulin resistance
uric acid
type diabetes